About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Monday, January 29th, 2018

The QualityStocks
Daily Stock List


Eguana Technologies, Inc. (EGTYF)

Streetwise Reports, Investors Hub, and Stockhouse reported on Eguana Technologies, Inc. (EGTYF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Eguana Technologies, Inc. is one of the leaders in power conversion and control systems for distributed energy storage. The Company designs and manufactures high performance power controls for commercial and residential energy storage systems. It is the foremost supplier of power controls for solar self-consumption, grid services, as well as demand charge applications at the grid edge. Listed on the OTCQB, Eguana Technologies is based in Calgary, Alberta.

Eguana Technologies is one of the leaders in power conversion and control systems for distributed energy storage. It delivers proven, durable, high quality solutions from its high capacity manufacturing facilities in Europe and North America. Additionally, the Company delivers grid edge power electronics for fuel cell, photovoltaic, and battery applications.

Eguana Technologies has thousands of its proprietary energy storage inverters installed in the European and North American markets. Its corporate vision is to become the top international supplier of intelligent power electronics for grid tied residential storage applications.

The Company has its AC Battery™. The Eguana AC Battery is a total grid ready power control solution. It accepts dispatch commands from any control network utilizing open communication protocols. The AC Battery is constructed around Eguana’s patented Bi-Direx power controls.

The AC Battery is 'control' ready. It can be commanded via a Sunspec-compliant ModBus interface using any third-party energy management system. The AC Battery is a suitable fit for small commercial and light industrial applications. It is compatible with all advanced battery technologies.

Eguana’s Patented "pulsed step wave" technology takes a different approach to reducing conducted losses through sharing the current across parallel bridges and recombining into the AC output waveform by way of a unique transformer topology and advanced control software. The single power conversion step further lessens losses. Also, it allows quicker and more stable control loops than conventional inverters.

Last month, Eguana Technologies announced that Sossin Group LLC (New York based) teamed up with Swezey Fuel and National Energy Connection (NEC) to offer a complete solar + storage package for Long Island residents. In addition to electricity cost savings, Swezey customers will have complete back up power mode provided by the Eguana AC battery. The Eguana AC Battery can be purchased separately for back up power installations or as part of the total package.

Today, Eguana Technologies announced the completion of a multi-year master supply agreement with its German automotive partner. The multi-year contract has an initial year forecasted value of $13 million.

The delivery expectations are to be completed within this calendar year. The initial product release of $3.2 million has been received. Planned shipments will commence this coming May followed by three more product releases.

Eguana Technologies, Inc. (EGTYF), closed Monday's trading session at $0.2447, up 19.37%, on 610,290 volume with 153 trades. The average volume for the last 60 days is 89,225 and the stock's 52-week low/high is $0.12/$0.246.

Sun Pacific Holding Corp. (SNPW)

Zacks and Marketwired reported on Sun Pacific Holding Corp. (SNPW), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Sun Pacific Holding Corp. works to protect the environment with smart green technology. The Company’s subsidiaries include Sun Pacific Power Corp, Street Smart Outdoor Corp, Bella Electrical LLC, National Mechanical Corp, and Sun Pacific Security Corp. Sun Pacific Holding has its corporate headquarters in Manalapan, New Jersey. The Company’s shares trade on the OTC Markets Group’s OTCQB.

In 2016, Company subsidiary, Sun Pacific Power, obtained final design of its Smart Solar Bus Shelter. It commenced deploying it in Sayreville and Howell, New Jersey. The Smart Solar Bus Shelter provides LED lighting for increased visibility and security and also other technological additions not formerly available.

Sun Pacific Power builds next generation solar panels and lighting products made chiefly in the United States. Sun Pacific Power has eight global manufacturing and assembly locations. This includes five in the USA.

Sun Pacific Holding’s subsidiary, Sun Pacific Security, offers customers the latest in security automation systems. This subsidiary enables one to view secure, live and recorded video of their property at any time on their computer, smartphone or tablet.

Recently, Sun Pacific Holding announced that Street Smart Outdoor, its wholly-owned subsidiary, contracted with the State of Rhode Island Transportation Authority. Mr. Nicholas Campanella, Sun Pacific Holding’s Chief Executive Officer, said, "Street Smart Outdoor Corp. has formally signed a ten year contract with the state of Rhode Island Transportation Authority to manage and sell advertising space on over 700 bus shelter faces which serve the local residents of Rhode Island."

In late November, Sun Pacific Holding announced the start of Sun Pacific Power’s contract with the city of Tallahassee. This involves the start of the installation and maintenance of Solar Powered Bus Shelters and Transit Amenities at hundreds of locations throughout Tallahassee, Florida.

The contract is with Star Metro. Star is the transportation authority in the State of Florida’s capital city Tallahassee. Sun Pacific is to provide street furniture and other transit amenities. This includes its solar powered Smart Shelters and benches throughout the city of Tallahassee, fixed routes on the campuses of Florida State University and Florida A&M University, and its unincorporated areas.

This week, Sun Pacific Holding announced its partnership with CrowdfundX, which is a FinTech marketing firm and developer of Dara, a semi-autonomous machine, which empowers public and private companies to streamline retail investor acquisition.

Sun Pacific Holding has engaged CrowdfundX in a 6-month contract. CrowdfundX takes advantage of a combination of Artificial Intelligence (AI) and digital marketing to help issuers acquire retail investors and shareholders at scale.

Sun Pacific Holding Corp. (SNPW), closed Monday's trading session at $0.33, up 9.63%, on 35,731 volume with 15 trades. The average volume for the last 60 days is 53,316 and the stock's 52-week low/high is $0.045/$0.82.

Strongbow Exploration, Inc. (SBWFF)

Stockhouse, 24hgold, MarketWatch, OTC Markets, Investors Hangout, Money Hub, and The Northern Miner reported on Strongbow Exploration, Inc. (SBWFF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Strongbow Exploration, Inc. is building a portfolio of strategic metals assets in North America and the United Kingdom (UK). The Company’s flagship project is the fully permitted, past producing South Crofty underground tin mine in Cornwall, UK. Strongbow is currently focusing on the construction of a water treatment plant so the now-flooded mine can be dewatered.

Strongbow Exploration’s shares trade on the OTC Markets Group’s OTCQB. The Company is headquartered in Vancouver, British Columbia. Strongbow Exploration is a member of the Osisko group of companies. Osisko Gold Royalties is the Company’s largest shareholder, presently owning 31 percent of the issued share capital.

Strongbow Exploration’s plan is to bring the South Crofty project to a project decision and complete a feasibility study (FS) in parallel with the mine dewatering process. The South Crofty underground tin mine in Cornwall hosts one of the highest grade tin resources globally. The project has the potential to be the only high-grade tin producer in Europe.

The Company acquired South Crofty in July 2016. The Project has a mine permit valid to 2071. It also has planning permission to build a new process plant.

In addition, Strongbow Exploration holds royalty on the Cantung and Mactung tungsten assets in the Yukon and Northwest Territories in Canada. The Company maintains a 100 percent interest in the 7,642 hectares Nickel King property, situated in the Northwest Territories.

Strongbow Exploration has its Coal Creek Project. The Coal Creek property consists of the CC 1 through CC 15 State of Alaska mining claims totaling 971.3 hectares (2,400 acres). The property is 11 kilometers (7 miles) southwest of Colorado Station on the Alaska Railroad.

The Company also has its Sleitat Tin-Silver Property. The Sleitat Property consists of the CAS 1 through 22 State of Alaska mining claims totaling 1,425 hectares (3,520 acres). This Property is in an uninhabited remote region within the boundaries of the Bristol Bay Native Corporation.

Today, Strongbow Exploration announced the closing of its earlier announced $7.17 million secured note financing from Osisko Gold Royalties Ltd. that would be convertible into a 1.5 percent net smelter returns royalty (NSR Royalty) on all metals and minerals produced from the Company’s South Crofty tin project.

Strongbow Exploration, Inc. (SBWFF), closed Monday's trading session at $0.127, even for the day. The average volume for the last 60 days is 2,872 and the stock's 52-week low/high is $0.101/$0.1812.

LD Holdings, Inc. (LDHL)

Tip.us, Wall Street Reporter, pressreleasepoint, Innovative Marketing, and Stock Guru reported previously on LD Holdings, Inc. (LDHL), and we report on the Company today, here at the QualityStocks Daily Newsletter.

LD Holdings, Inc. is a Financial and Management Holding Company listed on the OTC Markets Group’s OTCQB. Its focus is on acquiring businesses owned by Boomers who do not have an exit strategy. The Company’s emphasis is on delivering venture capital level returns without the venture capital level risk. LD Holdings (formerly known as Leisure Direct, Inc.) is based in Perrysburg, Ohio.

LD Holdings focuses on providing marketing, sales, and other business services, which represent target services to position client companies for sales and profit growth in preparation for their eventual sale. In addition, the Company focuses on maintaining a database of businesses for sale; maintaining a database of individuals with specific backgrounds and expertise for acquisition, evaluation, and strategizing the post-acquisition business model; and maintaining a database of investors.

LD Holdings will also maintain a database of young entrepreneurial managers. The Company will maintain a database of talented individuals with varied specific backgrounds. This will allow it to have expertise available for acquisition evaluation, and strategizing the post-acquisition business model for each potential acquisition, upon the financial aspects of the transaction being ascertained.

Furthermore, LD Holdings will look to acquire companies that have an existing management base that can assist in the transition to grow organically and profitably. Also, it will maintain and expand a database of investors to help finance acquisitions.

LD Holdings’ is focusing its immediate and near-term actions on executing a round of five acquisitions in the landscape architect, build and servicing space; implementing a transition and integration plan for newly acquired businesses; delivering revenue growth and operational efficiency targets; and positioning the public entity of LD Holdings for potential exchange up-listing and long term financial success.

The Company works to source Boomer businesses that fit LD Holdings’ acquisition criteria. LD Holdings will source and locate businesses with sales less than $25 million, profitable for the last 3 to 5 years, or have a well-defined path to profitability.

LD Holdings’ plan is to finance its goals via the use of a qualified and screened database of up to 3,000 accredited investors (Angels and Institutions) and 1,500 non-credited investors.

LD Holdings, Inc. (LDHL), closed Monday's trading session at $0.169, up 23.36%, on 24,844 volume with 11 trades. The average volume for the last 60 days is 2,126 and the stock's 52-week low/high is $0.04/$0.18.

Nippon Dragon Resources, Inc. (RCCMF)

OTC Markets Group, InvestorPlace, and Streetwise Reports reported previously on Nippon Dragon Resources, Inc. (RCCMF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Nippon Dragon Resources, Inc. is a hybrid mining & technology company. It has high potential and advanced stage mining assets combined with a unique and exclusive green mining method. The Company is active in the exploration and development of gold resources in the Province of Quebec.

The Company formerly went by the name Rocmec Mining, Inc. It changed its corporate name to Nippon Dragon Resources, Inc. in April 2014. Nippon Dragon Resources has its head office in Brossard, Quebec.

Nippon Dragon Resources has its Thermal Fragmentation mining method. This is a mining method that uses heat to 'spall' high-grade veins, considerably lessening the use of explosives. The method only extracts the mineralized ore with minimal dilution. The extraction process permits thermal fragmentation with an accuracy of 2 cm to quickly extract any type of hard rock up to 110 cm wide.

With this precision, high grade precious and base metal veins can undergo extraction without dilution. The thermal unit can be set up to extract a specific corridor. Thermal Fragmentation could be used as a stand-alone method or as a first-rate complement to any conventional hard rock mining operation.

The Company’s flagship gold property is Rocmec 1. This is a fully permitted project in Quebec. The project includes a 100-meter deep, two-compartment shaft, and an 844 meters’ decline, permitting access to four levels (50, 90, 110 and 130 meters).

Furthermore, Nippon Dragon has its Denain Project. This project covers two contiguous mining properties (Venpar and Vauquelin) totaling 24 mining titles. The Denain Project is roughly 60 km east of Val d'Or, Quebec.

The Company also has its Courville-Maruska exploration property in Courville Township, around 32 kilometers’ northeast of Val-d'Or, Quebec. The property consists of 20 mining claims encompassing an area of approximately 800 hectares. The property is on a gold-bearing quartz vein system.

Recently, Nippon Dragon Resources announced the confirmation of its strategic partnership agreement with Val d’Or Resources (VOR). This partnership agreement will enhance Nippon’s position as an industry leader with its exclusive and patented Thermal Fragmentation technology.

Via the creation of a new entity, Rocmec Gold, Inc., the new partnership is expected to substantially expand Nippon’s reach within Canada and other important markets. In the Joint Venture (JV), Nippon Dragon Resources will contribute certain assets and resources. VOR will contribute 16 million CDN dollars in cash, based on a predetermined schedule. At term, this will permit VOR to acquire a 49 percent interest in the JV.

Last month, Nippon Dragon Resources announced that it finalized negotiations with Metalfer Mining. This is to provide a Thermal Fragmentation equipment Unit that will be installed in their mining operation in Serbia.

The sale purchase agreement includes a Thermal Fragmentation Unit including a lance-burner and accessories. The sale purchase agreement also includes a four week orientation, on-site training and hands-on instruction in the proper use of the Process and adequate servicing of the Unit. Furthermore, the agreement includes monthly Licensing and Royalty fees.

Nippon Dragon Resources, Inc. (RCCMF), closed Monday's trading session at $0.0434, up 0.23%, on 3,400 volume with 3 trades. The average volume for the last 60 days is 47,987 and the stock's 52-week low/high is $0.03/$0.089.

Golden Predator Mining Corp. (NTGSF)

OTC Markets, Stockhouse, Junior Mining Network, Barchart, Gold Investment Letter, Penny Stock Hub, and The Street reported on Golden Predator Mining Corp. (NTGSF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Golden Predator Mining Corp. acquires and explores for mineral properties in the U.S. and Canada. The Company concentrates on its district scale, orogenic gold-in-quartz 3 Aces Project in the Yukon. Incorporated in 2008, the Company previously went by the name Northern Tiger Resources, Inc. It changed its name to Golden Predator Mining Corp. in April of 2014. Golden Predator Mining has its corporate office in Vancouver, British Columbia.

The 3 Aces Project is 357 km2 (35,700 hectares), 100 percent owned (subject to underlying royalties), and is a high-grade gold project (Orogenic Gold Model). It includes at least 6 mineralized areas. These are all positioned within and along favorable stratigraphic and structural zones, which extend more than 35km along trend.

A number of mineralized veins have been discovered to date. Many have visible gold occurrences. The 3 Aces Project hosts the two highest grade surface outcrops discovered so far in the Yukon.

The initial emphasis of the 2018 exploration program will be to drill wide-spaced diamond core holes into the major shear zones and folds associated with the postulated anticline. The work will start in the Central Core Area and move along strike and down dip following already identified gold-bearing structures.

In addition, the Company holds 100 percent of the advanced Brewery Creek Project in the Yukon. The Brewery Creek Mine is operated by Golden Predator Mining Corp.

The Brewery Creek Mine is 55km east of Dawson in the northwestern region of the Yukon. The target at this Project is an intrusion related gold deposit. Gold is the commodity at Brewery Creek.

Earlier this month, Golden Predator Mining reported the results of 42 Reverse Circulation (RC) drill holes completed in 2017 at the 3 Aces Project. Initial drilling is reported from the Diamonds Zone along with the Hearts/Clubs Corridor.

The Company stated that all areas encountered encouraging results and will see continued drilling this year. The final 43 RC holes completed in 2017 will be reported separately.

Gold mineralization ranging from anomalous to high grade was encountered in 30 of the 42 holes drilled across the Central Core. This includes the Hearts, Clubs, and the Diamonds Zones.

High-grade quartz veins continue to be encountered along with a growing abundance of disseminated and stockwork occurrences. These two kinds of mineralization are integral to Golden Predator Mining’s conceptual geological model.

In addition, this month, Golden Predator Mining reported results of 43 Grade Control drill holes at the 3 Aces Project. This includes the highest gold assays returned so far from drilling on the project.

The design of the drill holes was to investigate close-space variability in three different areas of the Spades Zone. This is to prepare for resource delineation drilling across the Central Core Area later in 2018.

The close-spaced Grade Control drilling was completed in three areas. All of these areas are now considered to be part of the larger central Spades Zone. Significant gold mineralization was encountered in 39 of the 43 holes.

Golden Predator Mining Corp. (NTGSF), closed Monday's trading session at $0.61, up 2.42%, on 25,600 volume with 9 trades. The average volume for the last 60 days is 38,641 and the stock's 52-week low/high is $0.48/$1.59.

Isodiol International, Inc. (ISOLF)

Stockhouse, InvestorsHub, OTC Markets, Investopedia, and Wealth Daily reported on Isodiol International, Inc. (ISOLF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Isodiol International, Inc. specializes in the development of pharmaceutical and wellness products. An international Bioactive Phytoceutical innovator, the Company’s growth strategy includes the development of over-the-counter (OTC) and pharmaceutical drugs, and expanding its phytoceutical portfolio. Isodiol is continuing global expansion into Latin America, Asia, and Europe. OTCQB-listed, Isodiol International is headquartered in Vancouver, British Columbia.

The Company is the market leader in pharmaceutical grade phytochemical compounds. Furthermore, it is the industry leader in the manufacturing and development of phytoceutical consumer products.

Isodiol International is the initiator of numerous firsts for the cannabis industry. This includes commercialization of 99 percent+ pure, bioactive pharmaceutical grade cannabinoids. It also includes micro-encapsulations and nanotechnology for the highest quality consumable and topical skin care products.

Isodiol International produces raw ingredients, consumer packaged goods such as dietary supplements, food and beverages, skin care, and pharmaceutical products for the worldwide healthcare market. Regarding raw ingredients, the Company develops natural phytoceutical derivatives and delivery technologies.

Concerning consumer products, it develops its own family of product brands for retail sale. It also develops white label products and brands for wholesale customers. Pertaining to pharmaceuticals, Isodiol supplies raw phytoceutical ingredients.

Isodiol International Inc announced this month the U.S. sales launch of ImmunAG™. This product is the market’s first non-cannabis cannabidiol (CBD) product derived from the hops plant. This is a time-released tablet. The ImmunAG tablet does not dissolve in the stomach. It dissolves in the lower intestine, therefore creating greater bioactivity.

Isodiol has acquired worldwide licensing rights for IsoDerm™ and five other proprietary pharmaceutical compounds to be delivered by the patented Direct Effects Technology™. This is a back of the neck delivery system from its developer Dr. Ronald Aung-Din, MD.

With this innovative non-systemic delivery system, a topical cream can be applied to the back of the neck (at the hairline). It is subsequently picked up by the free nerve endings in the dermis of the skin for a highly effective delivery of the compound.

Last week, Isodiol International announced that it entered into a definitive agreement in connection with its earlier announced Letter of Intent (LOI) to acquire Bradley’s Bioscience, Inc. Bradley’s is a foremost manufacturer and distributer of hemp oil and nicotine e-liquids.

Mr. Marcos Agramont, Isodiol International’s Chief Executive Officer, said, “The acquisition of Bradley’s Bioscience, a market poised to be a $61.4 billion-dollar industry by 2025 is another major milestone for the Company. Not only does this allow the Company to penetrate a new market, but we are now also able to provide consumers with a safer alternative to smoking. Overall, we believe Bradley’s Bioscience is a perfect fit with Isodiol and our long-term vision and we are very pleased to be moving forward with this agreement.”

Furthermore, Isodiol International has entered into a binding agreement to acquire 100 percent of C3 Global Biosciences (C3GBS). C3GBS is a cause driven organization. Its dedication is to developing sustainable health solutions via the advancement of cannabis science.

Isodiol International, Inc. (ISOLF), closed Monday's trading session at $1.12, up 14.29%, on 253,826 volume with 156 trades. The average volume for the last 60 days is 482,255 and the stock's 52-week low/high is $0.0513/$1.69.

BioRestorative Therapies, Inc. (BRTX)

Streetwise Reports, Investor Ideas, and ProActive Capital reported earlier on BioRestorative Therapies, Inc. (BRTX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

BioRestorative Therapies, Inc. is a life sciences company concentrating on adult stem cell-based therapies for diverse personal medical applications. It develops products and medical procedures utilizing cell and tissue protocols, principally involving adult stem cells. BioRestorative Therapies has its corporate, administrative, and laboratory operations in Melville, New York. The Company lists on the OTC Markets’ OTCQB.

The Company’s goal is to become a leader in providing medical procedures employing cell and tissue protocols, primarily involving adult stem cells (non-embryonic), and allowing patients to undergo minimally invasive cellular-based treatments.

BioRestorative’s products and medical procedures include brtxDISC™ (Disc Implanted Stem Cells), its Disc/Spine Program, and ThermoStem®, its Metabolic Program. brtxDISC™ is an investigational non-surgical treatment for bulging and herniated lumbar discs. brtxDISC™’s intention is for patients who have failed non-invasive procedures and face the prospect of surgery.

BioRestorative Therapies’ lead cell therapy candidate is BRTX-100. This product is formulated from autologous (or a person’s own) cultured mesenchymal stem cells collected from the patient’s bone marrow.

ThermoStem® is a treatment utilizing brown fat stem cells. ThermoStem® is under development for metabolic disorders. This includes diabetes and obesity. The Company is developing a cell-based therapy to target obesity and metabolic disorders employing brown adipose (fat) derived stem cells to produce brown adipose tissue (BAT). The intention of BAT is to mimic naturally occurring brown adipose depots that regulate metabolic homeostasis in humans.

BioRestorative Therapies is the beneficiary of a patent granted for a licensed curved needle device (CND). The design of it is to deliver cells and/or other therapeutic products or material to a site having damage in need of facilitated repair.

The Company’s intention is to advance the design of this curved needle device to facilitate the delivery of substances, including living cells, to specific locations within the body and reduce the potential for damage to neighboring structures.

Last week, BioRestorative Therapies announced the appointment of Mr. Adam Bergstein as Senior Vice President, Planning and Business Development. Mr. Bergstein will be responsible for strategic planning, business development, capital market activities, as well as related endeavors.

From 2008 until 2017, he founded and operated PharmaShield, an analytics enterprise. Mr. Bergstein has an MBA from the J.L. Kellogg Graduate School of Management with concentrations in finance and organizational behavior. In addition, he has a Bachelor of Arts degree in Economics with distinction from the University of Pennsylvania.

Mr. Mark Weinreb, BioRestorative Therapies’ Chief Executive Officer, said, "We are extremely excited to have Adam join BioRestorative at this important time of our development. With his industry expertise, capital markets experience and impressive track record, Adam will be a strong addition to our senior management team as we accelerate our clinical, regulatory and business development activities.”

BioRestorative Therapies, Inc. (BRTX), closed Monday's trading session at $3.19, up 1.27%, on 1,751 volume with 4 trades. The average volume for the last 60 days is 1,814 and the stock's 52-week low/high is $2.50/$5.01.

Umatrin Holding Limited (UMHL)

MarketWatch, OTC Markets, and BusinessWire reported on Umatrin Holding Limited (UMHL), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Umatrin Holding Limited sells and trades in beauty, personal care, health, and wellness products. It does so primarily in Malaysia. The Company markets its products to end-users and dealers via an online channel and a retail store. U Matrin Worldwide Sdn Bhd (270883-X) is a subsidiary of Umatrin Holding Limited. U Matrin Worldwide is based in Kuala Lumpur.

The Company Incorporated in the state of Delaware on February 2, 2005. Umatrin has 10 years’ experience in Internet performance and security.

Umatrin Holding originally incorporated to locate and negotiate with a targeted business entity for the combination of that target company with Umatrin Holding. To move forward with this vision, on January 6, 2016, Umatrin decided to acquire an operating company in Malaysia, called U Matrin Worldwide Sdn Bhd, into Umatrin Holding Limited. U Matrin Worldwide Sdn Bhd was awarded with a direct selling license by the Ministry of Domestic Trade and Consumer Affairs in Malaysia.

Umatrin Holding operates in greater than 25 nations and territories. It operates leading O2O (Online to Offline) marketplaces in the retail and wholesale trade.

Umatrin provides technology and services to enable consumers, merchants, and other participants to conduct business in its cloud ecosystem. Umatrin Holding has over five years’ experience in managing e-commerce sites, brand marketing, product development, as well as financial security.

For Home Appliances, Umatrin’s products include the Hyundai Waco Water Filter and the Hydrogen Alkaline Water Stick. For Healthcare, the Company offers the Nano Patch. This product is for maintaining a constant level of nutrients in the blood.

Umatrin is using advanced network technology and a strong management system that creates unlimited business brand space. The Company continuously introduces new products and combined O2O internet business model and career opportunities, which do not require huge sums of operating cost.

Umatrin has its Akero Secret product. Akero Secret is developed with 100 percent natural botanical active ingredients. It is a beauty product for clean and clear skin. The Akero Gold Series consists of Gold Toner, Gold Moisturizer, Gold Magical Cream, and Gold Cleanser.

The Company’s products also include Unibersih. This is an herbal essence used for the treatment of constipation, pigmentation, overweightness, bad breath, unsound sleep, lack of physical strength, indigestion, abdominal swelling, dry and pale skin, poor immune system, and more. Unibersih is a natural unpolluted herbal essence based Health Food Supplement. It is manufactured by GMP factories.

Moreover, Umatrin provides Sophielicous, an anti-aging supplement to enhance the longevity of skin cells; nano anti-aging face serum, nano eye contour serum, nano collagen face serum, nano whitening face serum, and nano vibration serum pen.

In addition, the Company offers its Akero Deep Cleanse Shampoo. This shampoo has three main ingredients. These are Pro Vitamin B5, Coconut Oil, and Guar Gum - an antioxidant. In addition, the Company has its alkaline water system.

Umatrin Holding Limited (UMHL), closed Monday's trading session at $0.06, up 3.45%, on 2,500 volume with 3 trades. The average volume for the last 60 days is 5,413 and the stock's 52-week low/high is $0.0002/$0.21.


The QualityStocks
Company Corner



The QualityStocks Daily Newsletter would like to spotlight EVIO, Inc. (EVIO). Today, EVIO, Inc. closed trading at $2.24, up 4.19%, on 137,976 volume with 180 trades. The stock’s average daily volume over the past 60 days is 107,407, and its 52-week low/high is $0.47/$3.10.

EVIO, Inc. (EVIO) is pleased to announce the appointment of Ron Russak as Vice President of Operations. Russak joins EVIO from a 17-year career at Quest Diagnostics where, as regional director, he had operational responsibility for 529 patient service centers and 228 inter-office phlebotomy sites throughout the western United States. Prior to joining Quest, Russak worked for Pennsylvania Hospital (of the University of Pennsylvania Health System) for 13 years where he served as administrative director of Laboratory Services.

EVIO, Inc. (EVIO), via the EVIO Labs division, is the nation's leading provider of accredited analytical testing, scientific research and advisory services to the regulated cannabis industry. EVIO Labs provides state-mandated ancillary services that are required to ensure the safety and quality of the nation's cannabis supply. EVIO Labs has performed over 50,000 tests during the past two years and grown from one laboratory in Oregon to nine labs spanning California, Oregon, Colorado, Massachusetts and Florida.

EVIO Labs is driving the cannabis testing industry by providing clients nationwide with consistent high-quality cannabis analytical services backed by quality control assurances. The company also provides advisory services that help cannabis producers and retailers enhance production processes, achieve regulatory compliance and meet quality goals.

EVIO Labs is on track to open 18 laboratories by the end of 2018 at locations around the United States. The Oregon-based company provides analytical services that include testing cannabis and industrial hemp flower, extracts and infused products. The labs specialize in performing the following tests:

  • Cannabinoid analysis, which properly characterizes the many primary cannabinoids found in cannabis including THC, CBD, and several other cannabinoids.
  • Terpene analysis, which identifies the aromatic compounds of the plant (terpene), which can help identify the therapeutic potential of a cannabis flower or extract.
  • Moisture content and water activity, which measure the moisture levels of dried cannabis and are indicators of microbiological growth potential.
  • Pesticide residue analysis of over 100 different pesticides, herbicides, fungicides, growth regulators and other agrochemicals that may be present on cannabis.
  • Detection of harmful residual solvents left behind in the cannabis extract production process.
  • Microbial testing screen for bacterial and fungal contamination in cannabis and cannabis-infused products.
  • Detection of heavy metals including lead, cadmium, mercury, and arsenic.

EVIO Labs is rapidly becoming the nation's leading cannabis biotechnology company. Led by a management team with extensive experience in designing and rolling out successful business ventures, product research and development, regulatory and compliance protocols, medical cannabis cultivation, production and analytical chemistry techniques, EVIO Labs is prepared to take advantage of today's fastest growing industry. Disclaimer

EVIO, Inc. Company Blog

EVIO, Inc. News:

EVIO Inc. Announces the Appointment of Ron Russak as Vice President of Operations

EVIO Inc. Announces 438% Revenue Growth for the Fiscal Year Ended September 30, 2017

EVIO Inc. Announces the Appointment of New President, Albert Lustig

Global Payout, Inc. (GOHE)

The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE). Today, Global Payout, Inc. closed trading at $0.03, off by 14.40%, on 12,690,996 volume with 368 trades. The stock’s average daily volume over the past 60 days is 14,141,181, and its 52-week low/high is $0.009/$0.16.

Global Payout, Inc. (GOHE) is pleased to announce that its majority owned subsidiary, MoneyTrac Technology, Inc. (“MTRAC”, the “Company”) has completed a Joint Venture Partnership agreement (“JV”) with Integrated Compliance Solutions, LLC (“ICS”), a premier “Seed to Banktm” provider of financial and regulatory compliance services and solutions for the multi-billion-dollar retail cannabis industry.

Global Payout, Inc. (GOHE) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships.

Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout's fully configurable "banking-in-a-box" web-based platform that can fulfill the front-to-back office processing requirements of domestic, foreign exchange and international payment service providers. This platform is designed to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

The Global Reserve Platform can manage practically any financial product, including core and traditional banking products, online banking, card management, mobile wallets, merchant payment processing, biometric payments and authentication management, bill payments and P2P payments, international remittances, government benefits management, loans management, FOREX, and SWIFT / ACH / SEPA payments. Powered by the Global Reserve Administrative module, the platform can be customized for enterprises across a multitude of business sectors.

Investment in financial technology (FINTECH) companies has grown dramatically in recent years with the role of today's banks shrinking and demand for improved financial solutions continuing to rise. As the industry has continued to expand rapidly, Global Payout's management team has directed its focus on identifying the most promising market sectors with FINTECH needs. The four core areas selected are logistics, small and medium enterprises (SME), banking and travel.

In 2015, Global Payout introduced MoneyTrac Technology Inc. as a majority owned subsidiary to more effectively focus on the development of financial technologies that specifically address many of the challenges that enterprises in a variety of alternative and "high-risk" market sectors are faced with in processing financial transactions. Powered by Virtu Network Solutions, the MoneyTrac Technology platform is one the most configurable and intuitive financial technology platforms available to alternative and "high-risk" enterprises and provides them with solutions that effectively manages everything from pin debit and virtual currency, to compliance and cash flow logistics.

With the global economy constantly becoming more diversified and connected, Global Payout is well positioned with the technology software solutions its team has developed to address many different needs worldwide. Management has committed itself to exploring and identifying every avenue possible for further establishing itself as a recognized leader in FINTECH solutions. Disclaimer

Global Payout, Inc. Company Blog

Global Payout, Inc. News:

MoneyTrac Technology, Inc. Establishes Joint Venture with Integrated Compliance Solutions, LLC, to Augment Compliance Services in Cannabis Industry

NetworkNewsAudio Announces Audio Press Release (APR) on Next-Generation Solutions Leveraging Blockchain

NetworkNewsWire Announces Publication on Blockchain Increasing Security and Efficiencies on an International Scale

Consorteum Holdings, Inc. (CSRH)

The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH). Today, Consorteum Holdings, Inc. closed trading at $0.003, up 7.14%, on 1,669,539 volume with 10 trades. The stock’s average daily volume over the past 60 days is 152,226, and its 52-week low/high is $0.0005/$0.008.

Consorteum Holdings, Inc. (CSRH) has extended its strategic agreement with Knockout Gaming, Inc. (http://nnw.fm/3BsLo). CSRH said that Knockout Gaming has enhanced its online gaming platform, and, under the agreement, Knockout will provide its platform to Consortium’s 359 Mobile, Inc., a wholly-owned subsidiary that recently completed the framework integration of its Universal Mobile Interface™ (“UMI”) platform into a mass scale transaction and settlement mobile gaming framework.

Consorteum Holdings, Inc. (CSRH) is a software development and mobile solutions company focused on the delivery of digital offerings to mobile devices. The company provides mobile offerings, delivery of mobile content, mobile payments solutions and products through a mix of direct offerings, partnerships, license agreements and joint venture arrangements. A multi-year transition from a transaction management company focused on transaction processing solutions and products for the payment processing and financial transaction markets to multiple business verticals deepens the company's commitment to deliver innovating solutions to end users who are using smart handset devices in radical new ways.

Consorteum Holdings, utilizing its Universal Mobile Interface™ ("UMI") solution, offers opportunities in numerous markets with its capacity to support fully regulated, regionally compliant financial and social transactions via web and mobile. The company's UMI technology has the capacity to provide solutions in FinTech, data analytics, secure payment processing, compliance lead transaction management and various digital social event sectors. The UMI platform allows cross operating system development to support all mobile devices while addressing the complex and highly regulated needs of the mobile FinTech industry.

Led by the development team at Consorteum's wholly owned subsidiary 359 Mobile Inc., the Company has created an end-to-end FinTech solution utilizing the company's UMI technology platform. Current mobile application and transaction solutions are plagued by poor experiences. Because UMI's technology platform is designed to work across innovative payment, experience and product solutions, 359 Mobile believes there are both direct and partnership opportunities for the 359 Mobile UMI solution.

Consorteum's primary sales and marketing strategy is focused on enabling and delivering solutions to the global mobile FinTech market with an emphasis initially on mobile gaming. The trend towards increased mobile gambling supports the need for a mobile platform such as the UMI to meet existing and new compliance regulations for the online gambling industry. The online gambling market is projected to double to nearly $1 trillion by 2021, according to a study by Juniper Research, with the majority of growth in this sector attributed to mobile devices. Consorteum's management team believes there are fresh opportunities in this sector such as Mobile Marketing Services providing one-to-one marketing experiences for consumers; offering real-time services to Mobile Sports Book operators; and providing fixed odds betting solutions as well as social-based transactional solutions.

Consorteum's management team includes Chairman and CEO Craig A. Fielding, a co-founder of the company with extensive experience in technology, programming and large system building; and Chief Operating Officer Patrick Shuster, who has over 25 years of business experience in sales, engineering, operations and marketing for the telecommunications industry. They are joined by John Osborne, SVP of Technology of ThreeFiftyNine Inc., an innovator in embedded systems hardware and software design; Patrick Doran, SVP of business development and marketing with over 30 years of diversified experience in major corporations as well as early stage companies; and Glenn Charlesworth, VP of Accounting, a seasoned executive with a solid track record in financial reporting, strategic planning, general management and operations, finance, start-up situations, and cash flow challenged operations.

Consorteum Holdings is committed to bridging the mobile divide by providing mobile connectivity, secure transactional processing and social connectivity solutions for both cloud and hosted based offerings in multiple business sectors. Disclaimer

Consorteum Holdings, Inc. Company Blog

Consorteum Holdings, Inc. News:

Consorteum Holdings, Inc. (CSRH) Extends Strategic Agreement with Knockout Gaming, Inc.

NetworkNewsBreaks – Why Consorteum Holdings, Inc. (CSRH) is “One to Watch”

Consorteum Holdings, Inc. to Release Wild Spots Bingo Mobile App in European Countries

Skinvisible, Inc. (SKVI)

The QualityStocks Daily Newsletter would like to spotlight Skinvisible, Inc. (SKVI). Today, Skinvisible, Inc. closed trading at $0.024, even for the day, on 36,643 volume with 5 trades. The stock’s average daily volume over the past 60 days is 229,416 and its 52-week low/high is $0.02/$0.33.

As deaths across the nation rise, families of victims struck down by the influenza A (H3N2) virus are beginning to sound the alarm (http://cnw.fm/4xHAu). The number of flu-related pediatric deaths this year has climbed to 30 so far. The crisis has prompted the director of the CDC, Brenda Fitzgerald, to remind the public that washing hands frequently can stop transmission of the virus (http://cnw.fm/K9lCY). A hand rub can work just as well if soap and water are not available, according to Fitzgerald. This is all good advice, says Skinvisible, Inc. (OTCQB: SKVI), which, through its Kintari subsidiary, produces the hand sanitizer, DermSafe®.

Skinvisible, Inc. (SKVI) through its wholly owned subsidiary Skinvisible Pharmaceuticals, Inc., is a Research and Development company whose patented Invisicare® technology can be used to revitalize or create new medical or skincare products, allowing a company that licenses Skinvisible's formulations to sell their own patented product and combat generic competitors.

A prescription dermatology product can generate $100 million or more a year, with the potential to lose 50-90% of that revenue when it goes off patent. Preserving that revenue is why the licensing of a product made with Invisicare is a very desirable option for many companies. The Company has developed a pipeline of 40 products using Invisicare, with a primary focus on optimizing the performance and increasing the value of "gold standard" dermatology drugs and licensing them to international and multi-national companies in the pharmaceutical, over-the-counter and cosmeceutical markets.

Invisicare® is a high performance topical and transdermal delivery system which enhances the delivery of drugs and other ingredients to and through the skin. The key to Skinvisible's patented technology and trademarked Invisicare® family of polymer delivery vehicles is its formula and process for combining hydrophilic and hydrophobic polymers into stable complexes in water emulsions. Invisicare® can be a key component of life cycle management, extending the life with a new patent-protected product, dramatically expanding the company's revenue stream.

Independent studies of Invisicare ® have shown the following benefits:

  • Active ingredients stay on the skin for up to four hours or more and resist wash off and rub off.
  • Delivery method results in improved efficacy, reduced skin irritation and lower required dosage.
  • Unique formulations are non-drying and provide the ability to control the release of active ingredients.
  • Products form a protective barrier, which means normal skin respiration and perspiration occur and the product wears off as part of the skin's natural exfoliation process.

Terry Howlett, President, founder and CEO of Skinvisible Inc., said the Company has more than 15 years of scientific research and product development experience. All development is conducted using stringent pharmaceutical standards. The Company has licensed a number of its formulations including a prescription hemorrhoid cream in the USA, its anti-aging Kintari® line of products and DermSafe®, its non-alcohol hand sanitizer to a licensee in China. Producing licensed products for the booming cannabis industry is also an important element of the company's business strategy.

Skinvisible's foray into the rapidly expanding market for medicinal and recreational cannabis products is already underway with the development of the company's first hemp-derived CBD (cannabidiol) products. Skinvisible has negotiated an exclusive licensing deal in Canada with Canopy Growth Corporation, one of the world's leading cannabis companies. As part of the company's overall growth strategy, Skinvisible is also negotiating with a Licensed Producer in Las Vegas where Skinvisible scientists will develop THC (tetrahydrocannabinol) products for the legal recreational and medical marijuana market for the USA. Notably, Skinvisible is actively pursuing potential licensees through-out the world where medical cannabis is legal. These licensees will have the exclusive right to manufacture and distribute Skinvisible's cannabis products within their territory.

"We are excited about the results we are already seeing just with our hemp-derived CBD products," Howlett says. "Our science shows that our CBD products release almost four times that of market leaders and our transdermal product had an 81% penetration rate at 6 hours. These results are significant and provide the difference between ordinary cannabis products and ones enhanced by Invisicare."

The Company's business model includes out-licensing its formulations for a development fee, license fee and on-going royalties in addition to selling its Invisicare polymers to its licensees. Disclaimer

Skinvisible, Inc. Blog

Skinvisible, Inc. News:

DermSafe from Skinvisible, Inc. (SKVI) Kills Killer Flu Virus H3N2 For Up to Four Hours

CannabisNewsBreaks – Skinvisible, Inc. (SKVI) to Enter Pain Management Therapeutics Market through Proposed Merger

Proposed Transdermal Treatment for Veterans with PTSD a Top Priority of Skinvisible, Inc. (SKVI) and Quoin Pharmaceuticals

IEG Holdings Corp. (IEGH)

The QualityStocks Daily Newsletter would like to spotlight IEG Holdings Corp. (IEGH). Today, IEG Holdings Corp. closed trading at $0.395, off by 1.25%, on 14,707 volume with 15 trades. The stock’s average daily volume over the past 60 days is 84,713 and its 52-week low/high is $0.14/$5.49.

Consumer loan provider IEG Holdings Corp. (IEGH) is exploring the possibility of creating a cryptocurrency to be backed by gold metal and registered with the SEC as a security. A recent article discussing the company reads: “Consumer loan provider IEG Holdings Corp. (OTCQB: IEGH), through wholly owned subsidiary Investment Evolution Crypto, LLC. (“Crypto”), recently announced its intention to create its own gold metal-backed cryptocurrency that could potentially be utilized when offering loans and accepting loan repayments. To view the full article, visit: http://nnw.fm/kDc26

IEG Holdings Corp. (IEGH) is a publicly traded, global leader in consumer finance providing small-sized online personal loans in the United States via a state-licensed operating subsidiary, Investment Evolution Corporation, under the consumer brand "Mr. Amazing Loans." Based in Las Vegas, the company originates consumer loans in 20 states: Alabama, Arizona, California, Florida, Georgia, Illinois, Kentucky, Louisiana, Maryland, Missouri, Nevada, New Jersey, New Mexico, Ohio, Oregon, Pennsylvania, Texas, Utah, Virginia and Wisconsin via its online platform and distribution network. IEGH is a licensed direct lender with state licenses and/or certificates of authority to lend in each state and offers all loans within the prevailing statutory rates.

Mr. Amazing Loans is a leading FinTech company specializing in dedicated loan amounts of $5,000 to $10,000 offered directly to consumers through an easy-to-use website known for its professional interaction with applicants. All loans are originated, processed and serviced out of the company's Las Vegas corporate offices, eliminating the need for physical locations in each state where IEGH is licensed to conduct business. The company's loans are unsecured consumer loans that mature in five years at interest rates significantly less than those of payday lenders. Consumers are able to receive same-day processing and are assured of no hidden or additional fees, no prepayment penalty, with repayment and interest rates fixed at 29.9% or less Annual Percentage Rate (APR) for the life of the loan.

The Center for Responsible Lending states the typical payday loan has rates ranging from 391% to 521% APR on loans that typically range from $100 to $1,000. Conversely, Mr. Amazing Loans's terms are designed with low fixed repayments to fit into consumer budgets with the added goal of helping clients reach a stronger financial position. Loan funds are deposited directly into an approved consumer's checking account and may be approved the same day after necessary application documentation is received.

IEG Holdings has also incorporated Investment Evolution Crypto, LLC., a 100 percent owned subsidiary, and tasked the new company with exploring business opportunities in the cryptocurrency/blockchain industry. Specifically, the subsidiary company will explore the legalities and economic risks of entering into a joint venture with IEGH's other 100 percent owned subsidiary company, Investment Evolution Corporation dba Mr. Amazing Loans. Among the questions to be answered during this development planning stage are whether Mr. Amazing Loans should accept repayment of customer loans in the form of leading crypto/blockchain currencies such as Bitcoin, provide the equivalent of USD $5,000 and $10,000 loans to consumers in cryptocurrencies, and potentially create and issue an Investment Evolution cryptocurrency.

Paul Mathieson, IEG Holdings' chairman and Chief Executive Officer, has over 19 years of finance industry experience in lending, funds management, stock market research and investment banking. He has been a member of the board of directors at IEGH since 2012 and of its subsidiary since 2009. Mathieson founded IEG Holdings Limited in Sydney, Australia, launching the Amazing Loans business in that country in 2005 and then in the United States via IEGC in 2010. He was awarded Ernst & Young's 2007 Australian Young Entrepreneur of the Year (Eastern Region). Mathieson is joined by Carla Cholewinski, who serves as chief operating officer with over 37 years of experience in the finance industry including banking, credit union management, regulatory oversight, debt securitization and underwriting. Disclaimer

IEG Holdings Corp. Blog

IEG Holdings Corp. News:

NetworkNewsBreaks – IEG Holdings Corp. (IEGH) Intends to Create Cryptocurrency Backed by Gold Metal

IEG Holdings Corp. (IEGH) Exploring Creation of Gold Metal-backed Cryptocurrency

IEG Holdings Urges LendingClub Board to Enter into Negotiations with IEG Holdings and to also Explore Opportunities in the Crypto/Blockchain Sector

Medical Cannabis Payment Solutions (REFG)

The QualityStocks Daily Newsletter would like to spotlight Medical Cannabis Payment Solutions (REFG). Today, Medical Cannabis Payment Solutions closed trading at $0.06595, off by 2.30%, on 378,265 volume with 44 trades. The stock’s average daily volume over the past 60 days is 804,740, and its 52-week low/high is $0.0161/$0.18.

Although marijuana was one of the fastest-growing industries over the last couple of years and is expected to continue at the same pace throughout 2018 and beyond, authorized businesses and vendors still have a hard time managing their finances and customers in the absence of banking services. With most banking institutions unable to open their doors to legal marijuana businesses because the substance is still classified as an illegal drug by the federal government, it is up to companies such as Medical Cannabis Payment Solutions (REFG) to provide the industry with fully secure, state-of-the-art financial services.

Medical Cannabis Payment Solutions (REFG), headquartered in Cheyenne, Wyoming, is a first-tier merchant processing cannabis industry pioneer, offering one of the first and only comprehensive card processing operations of its kind to serve the state-sanctioned medical marijuana industry. The company's state of the art system, which also tracks sales and tax collection, and eliminates the need to deal in cash-only transactions.

Through its robust, closed-loop merchant processing system, the company's unique "StateSourced" proprietary system enables authorized operation under FinCEN parameters and complies with all regulatory frameworks. StateSourced is tailored to deliver full-spectrum merchant processing services, providing the convenience of modern commercial card processing resources and making it the first operation of its kind geared to the legal cannabis industry.

StateSourced is not a prepaid or gift card, which is an important variable for merchants since standard banking institutions have not offered this form of payment processing to the legal cannabis industry. Federal law still considers marijuana illegal under the Controlled Substances Act, although 29 states and the District of Columbia have legalized the plant either for medicinal or recreational uses or both. This restriction has kept financial institutions at bay since most banks are federally insured and haven't been inclined to venture into the nascent industry.

Medical Cannabis Payment Solutions is able to offer its StateSourced card on a state-by-state basis where the card can be used in purchasing product from a legal, authorized vendor, providing a much-needed option for consumers and businesses alike. In another first, the company is collaborating with First Bitcoin Capital Corporation to integrate First Bitcoin's cryptocurrency ($Weed) with Medical Cannabis Payment Solutions' StateSourced payment gateway. This collaboration will allow state-licensed marijuana establishments across the nation to accept both StateSourced debit cards and cryptocurrencies such as WeedCoin and Bitcoin.

Medical Cannabis Payment Solutions president and CEO Jeremy Roberts and his executive team are working with state lawmakers to introduce legislation in an effort to address the growing problems in banking for the medical cannabis industry. For companies in the emerging legal cannabis industry, where retail and non-retail transactions such as vendor payments and payroll are almost exclusively paid for with cash, the solutions offered by StateSourced can help businesses avoid the inherent risks associated with a cash-intensive sector. Medical Cannabis Payment Solutions has also signed its first StateSourced contract with a Las Vegas-based vertically integrated marijuana establishment.

"We've completed our transition from development stage to revenue stage," says Roberts. "We have just started our business development efforts and the market is responding very well. We anticipate having many more, similar releases."

Medical Cannabis Payment Solutions provides end-to-end management across multiple systems for medicinal marijuana operations. The company solves the fragmentation problem experienced by many of these rapidly growing companies by identifying tools that are important to dispensaries and customizing those tools to meet the specific needs of this unique industry. Disclaimer

Medical Cannabis Payment Solutions Company Blog

Medical Cannabis Payment Solutions News:

Medical Cannabis Payment Solutions’ (REFG) Proprietary Platform Helps Expand Cannabis Industry’s Banking Options

NetworkNewsBreaks – Medical Cannabis Payment Solutions (REFG) Provides Secure Payment Processing Solution to Cannabis Industry

Medical Cannabis Payment Solutions (REFG) Breaking the Cannabis Payment Logjam

Lexaria Bioscience Corp. (CSE:LXX) (OTCQB:LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP). Today, Lexaria Bioscience Corp. closed trading at $1.85, off by 2.12%, on 355,047 volume with 603 trades. The stock’s average daily volume over the past 60 days is 517,878 and its 52-week low/high is $0.27/$2.54.

Lexaria Bioscience Corp. (CSE:LXX) (OTCQB:LXRP) has developed DehydraTECH™, a drug delivery platform that can be applied to various ingestible products such as foods, beverages, oral suspensions, tablets, capsules and more. An article discussing the company’s innovative drug delivery technology reads: “Lexaria’s DehydraTECH™ oral digestion technology is a ‘back office’ process that allows non-psychoactive cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (“NSAIDs”) and nicotine to be absorbed at much higher rates.

Lexaria Bioscience Corp. (LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body's gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria's products and others on the market is the company's disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the "unusual" taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company's technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria's processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government's National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria's unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience's business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company's patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria's lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world's most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria's revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company's growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets. Disclaimer

Lexaria Bioscience Corp. Blog

Lexaria Bioscience Corp. News:

NetworkNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Sees Potential to Lower Medication Doses Using Advanced Drug Delivery

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Technology Offers Potentially Safer Method of Delivering Drug Therapies

Lexaria Enters Licensing Agreement with Canadian Cannabis Chocolate Manufacturer

Petroteq Energy Inc. (TSX.V:PQE) (OTCQX:PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (PQEFF). Today, Petroteq Energy Inc. closed trading at $1.25, off by 3.10%, on 41,258 volume with 74 trades. The stock’s average daily volume over the past 60 days is 102,604, and its 52-week low/high is $0.015/$1.8892.

NetworkNewsAudio announces the Audio Press Release (APR) titled "Blockchain Yields Strong Potential in Global Supply Chain Management," featuring Petroteq (TSXV: PQE) (OTCQX: PQEFF). To hear the NetworkNewsAudio version, visit LINK. To read the original editorial, visit LINK.

Petroteq Energy Inc. (TSX.V: PQE) (OTCQB: PQEFF), with headquarters in Canada, seeks to create the world's largest pure-play cobalt exploration and development company. The company's current focus is on its Greater Cobalt Project located in Silver Centre, Ontario. The company is also in the midst of a three-way merger with Cobalt One Ltd. and CobalTech Mining Inc. and on completion First Cobalt will control over 10,000 hectares of prospective land and 50 historic mining operations in the Cobalt Camp in Ontario, Canada, as well as a mill and a permitted refinery facility.

The merger agreements with Cobalt One Ltd. and CobalTech Mining Inc., announced earlier this year, will result in a combined land position of more than 10,000 hectares (nearly 25,000 acres) in the Cobalt Camp containing approximately 50 past cobalt/silver producers and working mines. Initial test results from a mineralogical assessment of sample material taken from various historical mines located throughout the Cobalt Camp show both cobalt-rich and silver-rich mineralization styles. Samples taken at the former Bellellen mine, located within the Greater Cobalt Project in Ontario, show high grade cobalt assays, prompting First Cobalt to increase its drilling program at that site.

Petroteq Energy Inc. is moving quickly to leverage its potential against an economic background that estimates global consumption for refined cobalt is set to grow at an average rate of approximately 5 percent per annum for the next 10 years. The electric vehicle market, in particular, is driving this sector since more than 50 percent of the world's current production of cobalt is used in the manufacture of rechargeable lithium-ion batteries. The global lithium-ion battery market, as estimated by Zion Market Research, indicates the value at around USD $31 billion in 2016 and is expected to generate revenue of nearly USD $68 billion by end of 2022, growing at a compound annual growth rate of slightly above 17 percent.

The company's clear pathway to production and cash flow generation includes being one of only four fully permitted cobalt extraction refineries in Canada with significant material and processing infrastructure on site. With the price of cobalt increasing significantly and its importance in the growing battery market underpinning a strong long-term demand forecast, Petroteq Energy Inc. and its mining interests are primed for success.

Petroteq Energy Inc. President and CEO Trent Mell, a mining executive and capital markets professional with extensive international transactional experience, is joined by a team of reputable and seasoned deal-makers, mine builders and mine operators with decades of global experience in exploration, business development, geoscience, engineering and finance. Disclaimer

Petroteq Energy Inc. Company Blog

Petroteq Energy Inc. News:

NetworkNewsAudio Announces Audio Press Release (APR) on Blockchain's Core Value in Global Supply Chain Management

Petroteq Energy Announces Update on Private Placements

NetworkNewsWire Announces Publication on Blockchain’s Potential to Revolutionize Supply Chain Management

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)

The QualityStocks Daily Newsletter would like to spotlight PreveCeutical Medical Inc. (PRVCF). Today, PreveCeutical Medical Inc. closed trading at $0.45, off by 4.26%, on 59,846 with 34 trades. The stock’s average daily volume over the past 60 days is 3,697, and its 52-week low/high is $0.01/$0.80.

NetworkNewsAudio announces the Audio Press Release (APR) titled "Fast-Growing Cannabis Industry Drives Biotech Research, Innovative Medical Therapy Development," featuring PreveCeutical Medical Inc. (OTCQB: PRVCF) (CSE: PREV) (FSE: 18H). To hear the NetworkNewsAudio version, visit LINK. To read the original editorial, visit LINK.

PreveCeutical Medical Inc. (PRVCF), headquartered in Vancouver, British Columbia, Canada, is a health sciences company dedicated to researching and developing innovative options for preventive and curative therapies utilizing organic and Nature Identical™ products. The company is strategically staking out select positions in the medically acute areas of diabetes and obesity, pain management, neurological disorders and cancer.

PreveCeutical Medical Inc. had its beginnings in 2009 when Stephen Van Deventer, a seasoned businessman and venture capitalist, and Kimberly Van Deventer, a successful entrepreneur, met and formed a business partnership. The duo created Cornerstone Global Partners, a venture capital and business development company, and became involved in numerous ventures including building companies such as Aurora Cannabis Inc. Taking their interest in the health and wellness market further, the pair began researching how nature and science can work together to benefit health-conscious consumers. Coining and trademarking the word "PreveCeutical" – a combination of the words "preventive" and "pharmaceutical" – was a precursor to the company's formation and incorporation in October 2015.

The company's first product was developed in the Dominican Republic and is now marketed and distributed worldwide by PreveCeutical. It is a Caribbean Blue Scorpion venom product sold under the trade name CELLB9®. This product is an oral dilute solution infused with select peptides sourced exclusively from the blue scorpion (Rhopalurus princeps) found only in Caribbean nations. The active potentiated ingredients in CELLB9, which have been used in over 40 countries for over a decade, appear to support health at a deep, cellular level. PreveCeutical's research team is using proprietary chemistry to generate Nature Identical™ peptides derived from natural compounds found in Caribbean Blue Scorpion venom with the goal of eventually treating, regulating and preventing cancer progression. Peptides are also being used to target an array of disease indications including metabolic disorders, pain management, cancers, cardiovascular and infectious diseases.

PreveCeutical is developing the first nose-to-brain delivery system of cannabinoids (CBDs) with a novel process that prepares insoluble drug-containing nano-micelles and successfully incorporating them into a proprietary sol-gels application, essentially creating a targeted drug delivery vehicle. Intended for use via a nasal spray, this unique formulation rapidly gels upon contact with mucosal tissue, which paves the way for direct nose-to-brain delivery. This novel application eliminates first pass metabolism (stomach, intestines, liver), potentially improving bioavailability and delivering extended time release formulations that may alleviate side effects of higher dosage therapeutics. This CBD-based patented formula is projected to be deployed in selected markets with licensed medical marijuana companies within 18 months.

PreveCeutical is working with four leading Australian research centers to develop a curative therapy for diabetes and obesity. This four-year program involves engineering a novel approach that selectively targets the gene that encodes for the protein PTP-1B, which is implicated and over-expressed in both type-2 diabetes and obesity. PreveCeutical's gene-silencing technology would effectively "turn off" the genetic signal which leads to the over-production of this key protein molecule, bringing it back down to safe, normalized levels, and prevent the body from storing excessive fat. Diabetes kills one person every six seconds, with more than $800 billion spent globally on the disease.

Another exciting joint venture, established with Sports 1 Marketing, will focus on the therapeutic potential in the peptides and proteins connected to the Caribbean Blue Scorpion venom to potentially treat mild brain injury concussions. Developing a therapeutic product geared towards athletes who suffer from concussions could help alleviate suffering experienced by those who are affected by head trauma.

PreveCeutical Medical's science and research team is led by Dr. Harendra (Harry) Parekh, Ph.D., who is based at the University of Queensland's (UQ) Pharmacy Australia Centre of Excellence (PACE), and Dr. Makarand Jawadekar, Ph.D., whose 28 years of R&D experience with Pfizer Inc., is applicable in his role as chief science officer. Research collaborators include Dr. Rakesh Veedu, an emerging expert internationally in the field of molecular medicine, and Professor Grant Ramm, who is currently head of a leading medical research institute located in Brisbane, Australia.

PreveCeutical Medical is partnering with leading industry experts and companies in its quest to be a leader in the preventive health sciences sector. Its Research and Development partnership with UniQuest, the main commercialization company for the University of Queensland, provides PreveCeutical with the rights to all intellectual property arising from projects created under the agreement. PreveCeutical Medical Inc.'s management team brings an extensive portfolio of research experience, product development, deep corporate strategy and capital markets leadership to the company's core. Disclaimer

PreveCeutical Medical Inc. Company Blog

PreveCeutical Medical Inc. News:

NetworkNewsAudio Announces Audio Press Release (APR) on the Cannabis Industry Driving Medical Therapy R&D

NetworkNewsWire Announces Publication on Advancements in Cannabis Industry Biotech Therapy

Fast-Growing Cannabis Industry Drives Biotech Research, Innovative Medical Therapy Development


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters



(NGMC) +127.27%


(ARFXF) +45.79%


Trader Power News
(IMMR) +36.24%

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251